Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.

OBJECTIVE: To compare the use of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis (kala-azar). METHODS: A total of 102 patients with confirmed kala-azar were treated in a mission hospital in West Pokot region, Kenya, with sodium stibogluconate (20 mg/kg/day f...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Moore, E., O'Flaherty, D., Heuvelmans, H., Seaman, J., Veeken, H., de Wit, S., Davidson, R. N.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: World Health Organization 2001
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2566419/
https://ncbi.nlm.nih.gov/pubmed/11417033
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia